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Perspective
It is truly remarkable that our bodies turnover/
recycle roughly one million cells every second 
(Henson and Hume, 2006; Ravichandran and 
Lorenz, 2007). These include excess cells that 
are being constantly generated in tissues as part 
of normal development, used/aged cells, and 
damaged cells that arise from disease or infec­
tions (Savill et al., 1993; Henson and Hume, 
2006). The clearance of such dying cells is me­
diated either by phagocytes that are professional 
engulfers (such as macrophages and immature 
dendritic cells; Aderem and Underhill, 1999) or 
neighboring cells (such as fibroblasts and epi­
thelial cells; Monks et al., 2008). The quick and 
efficient removal of unwanted cells is important 
for “making space” for living cells, and for main­
taining the function of tissue, and in turn, a 
healthy organism (Savill et al., 2002; Henson, 
2005;  Henson  and  Hume,  2006).  Uncleared 
dying cells can undergo secondary necrosis, and 
the release of intracellular contents from these 
cells has been linked to autoimmune diseases 
(Savill and Fadok, 2000; Nagata et al., 2010).
Under normal conditions, the clearance pro­
cess is rapid such that even in tissues with high 
cellular turnover, very few apoptotic cells are seen; 
this led to an initial hypothesis that the basal ca­
pacity for cell clearance is very high (Gardai et al., 
2006). However, there are many disease states 
where uncleared corpses/debris are seen, includ­
ing systemic lupus erythematosus, atherosclerosis, 
Alzheimer’s disease, and Parkinson’s disease 
(Camins et al., 2008; Gorman, 2008; Calissano   
et al., 2009; Nagata et al., 2010). This suggests 
that the capacity for cell clearance may not be as 
large as initially thought; rather, in the context of 
a tissue there may be a regulated balance between 
the numbers of apoptotic cells, the numbers of 
phagocytes, and their capacity for uptake. There­
fore, defining the specific steps by which apop­
totic cells are recognized and removed quickly is 
important for understanding diseases associated 
with defective clearance and for potentially ma­
nipulating the engulfment machinery for future 
therapeutic benefits.
The engulfment process can be broadly bro­
ken down into four major steps (Lauber et al., 
2004; Fig. 1). The first step involves find­me   
signals released by apoptotic cells, which help   
attract phagocytes to the sites of death within a 
tissue (Gregory, 2009). The second step is the 
exposure of eat­me signals on the apoptotic cell 
surface, which promotes the specific recognition 
by the phagocyte and subsequent internalization 
of the corpse (Grimsley and Ravichandran, 2003). 
The third step is the processing of the ingested 
cargo by the phagocyte, where the engulfed 
corpse goes through a series of phagosome matu­
ration steps, eventually leading to its degradation 
(Kinchen and Ravichandran, 2008, 2010). The 
fourth step, loosely denoted as post­engulfment 
consequences, involves the release by the phago­
cyte  of  antiinflammatory  cytokines  and  other 
modifiers  that  are  elicited  during  recognition   
and processing (Savill and Fadok, 2000; Savill   
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a high turnover (e.g., thymus or bone marrow), in the basal 
state there are very few apoptotic cells seen. However, un­
cleared apoptotic cells can become evident in these tissues 
when large numbers of cells are induced to undergo apoptosis, 
or in the context of defective engulfment (Henson and Hume, 
2006; Elliott and Ravichandran, 2010). Recent studies have 
suggested that the apoptotic program is rather closely linked 
to the prompt removal of these cells (Gregory, 2009). Early 
evidence from elegant genetic studies in Caenorhabditis elegans 
suggested that apoptotic cells may be recognized by phago­
cytes and cleared well before the apoptotic cells are fully dead 
(Hoeppner et al., 2001; Reddien et al., 2001). This suggested 
that there might exist a mechanism by which the apoptotic 
cells advertise their own presence at the earliest stages of death. 
In addition, this led to the concept that find­me signals re­
leased from apoptotic cells can attract phagocytes to promote 
rapid clearance in vivo (Ravichandran, 2003).
Are there find­me signals in mammalian systems? Recently, 
several studies reported potential find­me signals released by 
apoptotic cells (Lauber et al., 2003; Gude et al., 2008; Truman 
et al., 2008; Elliott et al., 2009). These include lysophosphati­
dylcholine, fractalkine, nucleotides ATP and uridine 5 tri­
phosphate (UTP), and sphingosine 1­phosphate (S1P). All of 
these are capable of attracting monocytes, although only frac­
talkine and nucleotides have been shown to be capable of 
functioning as find­me signals under in vivo conditions   
(Truman et al., 2008; Elliott et al., 2009). The identification of 
et al., 2002; Henson, 2005). Collectively, these events mediate 
the selective and immunologically silent versus immunogenic 
removal of apoptotic cells in vivo (Green et al., 2009).
Over the past several years, several laboratories have helped 
identify the key molecules involved in these steps, as well as 
several molecular pathways that orchestrate the safe disposal of 
apoptotic cells (Wu and Horvitz, 1998a,b; Hamon et al., 2000, 
2002; Reddien and Horvitz, 2000; Gumienny et al., 2001; 
Zhou et al., 2001a,b; deBakker et al., 2004; Kinchen et al., 
2005; Yu et al., 2006). In this Perspective, I will focus on re­
cent developments in two areas, the find­me and eat­me sig­
nals of apoptotic cells, which have caused significant excitement 
in the apoptosis and engulfment fields. As is often the case with 
interesting observations, these have also raised several funda­
mental issues that are puzzling or unexplained by the existing 
data. I will attempt to address some of the complexities and 
gaps in knowledge, and present some possible suggestions for 
moving forward. To keep this review focused, I primarily ad­
dress events in the context of classical apoptosis that is largely 
nonimmunogenic; the reader is referred to other articles cov­
ering the modifications and responses of the immune system to 
necrotic and other immunogenic types of cell death (Green   
et al., 2009; Zitvogel et al., 2010).
Find-me signals: the beginnings of a fatal attraction
One of the striking anecdotal observations consistently ob­
served over many years is that even in tissues known to have 
Figure 1.  Different steps involved in efficient apoptotic cell clearance. The find-me signals (such as low levels of nucleotides ATP and UTP, frac-
talkine, lysophosphatidylcholine, or sphingosine 1-phosphate) released by apoptotic cells help attract motile phagocytes to the proximity of the cell un-
dergoing apoptosis. The phagocytes then use engulfment receptors on their surface to engage eat-me signals on apoptotic cells. For clarity, only the 
PtdSer on the apoptotic cells engaged by cognate receptors is depicted. Engagement of the engulfment receptors (linked to PtdSer recognition) has been 
shown to stimulate release of antiinflammatory cytokines such as TGF-b, IL-10, and prostaglandin E2 (PGE2). The intracellular signaling induced within 
the phagocyte by the ligand–receptor interactions leads to cytoskeletal rearrangements and internalization of the dying cell. The phagocyte processes the 
engulfed corpse through a series of steps, and proper digestion seems to be important for continued uptake of other dying cells by phagocytes.JEM VOL. 207, August 30, 2010  1809
Perspective
differing molecular sizes, it is likely there are distinct mecha­
nisms for their release. Another important point is that apop­
totic cells also appear to secrete stop signals, such as lactoferrin, 
which actively prevents neutrophil recruitment (Bournazou   
et al., 2009). It has long been known that clearance of apoptotic 
cells that occurs routinely in tissues often involves nonimmu­
nogenic clearance via monocytes, without neutrophil recruit­
ment and inflammation (Savill, 1997; Savill et al., 2002). 
Therefore, defining the specific channels or mechanisms of 
find­me signal release may be used for therapeutic purposes, 
for example to specifically attract monocytes for nonimmuno­
genic clearance and resolve inflammation.
Find-me not the only function?
Another question is whether all apoptotic cells need to send 
out find­me signals. It is easy to envision why a dying thymo­
cyte, which is likely not going to be cleared by a neighboring 
thymocyte (not phagocytic), would have to recruit thymus­
resident phagocytes. However, an epithelial cell undergoing 
death, which might be eaten by a neighboring epithelial cell, 
may not need to send a find­me signal. Similarly, in C. elegans, 
neighboring cells often clear the apoptotic cells, and phago­
cytes need not travel to find the dying cells (Kinchen and 
Hengartner, 2005). This raises the question of why cells have 
find­me signals at all—or do find­me signals have other roles? 
It is noteworthy that lung epithelial cells also release ATP after 
apoptosis induction (Elliott et al., 2009). One intriguing pos­
sibility is that the find­me signals such as nucleotides or S1P 
could activate or prime phagocytes and improve their phago­
cytic capacity. In Drosophila, apoptosis induces up­regulation of 
the engulfment machinery in neighboring cells (MacDonald 
et al., 2006; Ziegenfuss et al., 2008). In mammals, the bridg­
ing molecule MFG­E8, which can decorate an apoptotic cell 
and facilitate engulfment, is expressed in activated, but not 
resting, macrophages (Hanayama et al., 2002). Thus, macro­
phages somehow must be recruited, up­regulate MFG­E8, 
garnish their apoptotic meal, and then engulf the target. One 
possibility is that the find­me signals released by apoptotic cells 
would serve not only to attract phagocytes, but also to up­
regulate engulfment components in the recruited phagocytes 
(Fig. 2). If so, in the context of engulfment by a neighboring 
epithelial cell, perhaps the find­me signals act not as true find­
me signals but rather help activate the engulfment machinery 
in their neighbor. Find­me signals may also influence immu­
nogenic versus nonimmunogenic responses to apoptotic cells 
(Green et al., 2009; Zitvogel et al., 2010). Hopefully, future 
experiments will test this possibility.
Eat-me signals: phosphatidylserine and its receptors
Although find­me signals can get phagocytes to the proxim­
ity of apoptotic cells within a tissue, the specific recognition 
of the dying cell among the neighboring live cells depends on 
eat­me signals exposed by the apoptotic cells (Lauber et al., 
2004; Gardai et al., 2006). To date, multiple eat­me signals 
have been identified (Gardai et al., 2006). These include ex­
posure of phosphatidylserine (PtdSer), changes in charge and 
several distinct find­me signals established the idea that apop­
totic cells actually make an active effort to attract phagocytes. 
Several interesting questions ensue from these observations.
The basis behind the notion of find­me signals is that a 
chemotactic gradient would serve to attract the phagocytes. 
But what is the range of the gradient set up by these find­me 
molecules, and how is such a range determined? Most likely, 
the range would be determined by the tissue concentration of 
a given find­me molecule, and how quickly such a molecule 
is degraded. One could envision that if a find­me signal had 
a short half­life, and were restricted to the local tissue, it 
would act short range to attract resident phagocytes to the 
proximity of the dying cell. In contrast, if the find­me signals 
can get out of the tissues and into the circulation, they might 
attract phagocytes from circulation. As of now, we only 
know of short­range find­me signals. In the case of nucleo­
tides, they can be readily degraded by extracellular nucleotid­
ases (Elliott et al., 2009), and therefore their chemoattraction 
may be largely restricted to phagocytes resident within the 
tissue.  In  the  context  of  clearing  thymocytes  undergoing 
apoptosis, disrupting the nucleotide find­me cue resulted in 
uncleared corpses in the thymus (Elliott et al., 2009). How­
ever, it is not known whether a given phagocyte responding 
to the call of an apoptotic thymocyte is a nearby first re­
sponder, or comes from the other end of the thymus. This 
would obviously depend on the distance of a gradient set up 
by the ATP/UTP (~100 nM) released by an apoptotic lym­
phocyte (Elliott et al., 2009), but this is really difficult to pre­
cisely  establish  in  vivo.  It  is  important  to  note  that  early 
apoptotic cells release very small amounts of ATP (<2% of 
intracellular ATP), which should be distinguished from ne­
crotic cells that may release much of their ATP content. 
Marking particular macrophages and tracking their motion in 
real time toward a particular thymocyte may provide some 
answers. Lysophosphatidylcholine (LPCs; Lauber et al., 2003) 
and S1P (Gude et al., 2008) have not been tested in tissue 
models; therefore, it is difficult to assess their range. How­
ever, even if they were not rapidly degraded, LPC and S1P 
are present in high concentrations in circulation (much higher 
than what is reported to be released from dying cells), sug­
gesting  that  they  likely  work  locally  and  may  not  attract 
phagocytes from circulation. Although studies to date have 
considered the different find­me signals in isolation, if multi­
ple find­me signals are released from the same apoptotic cell, 
they may act in concert, and may be more efficient in attract­
ing phagocytes locally as well as from the circulation. This 
possibility needs to be explored.
Another interesting unanswered question is how the vari­
ous find­me signals are released from apoptotic cells. It is clear 
from the existing work that these soluble mediators are, in­
deed, released when the apoptotic cells are intact, with no ap­
parent leakage of cellular contents, and that the release is caspase 
dependent. This suggests that there may be channels or other 
mechanisms that mediate the release of these soluble mediators 
from inside the apoptotic cells. Given the varied nature of   
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with high affinity (Hanayama et al., 2002, 2004). A second 
region of MFG­E8 can simultaneously engage integrin vb3 
on phagocytes and thereby mediate PtdSer­dependent up­
take of apoptotic cells. Two other bridging molecules, Gas6 
and protein S, are involved in linking PtdSer exposed on 
apoptotic cells to Tyro­3–Axl–Mer family of receptors (de­
noted as TAM receptors) on phagocytes (Scott et al., 2001; 
Rothlin et al., 2007; Lemke and Rothlin, 2008). An impor­
tant role for this family has been established through single 
and combined knockout of the TAM family members in 
mice; these receptors appear important for clearance of apop­
totic cells in the eye, testes, thymus, and other tissues (Prasad 
et al., 2006; Lemke and Rothlin, 2008). In addition to the 
aforementioned receptors and bridging proteins, the mem­
brane proteins CD36 and CD68, and the soluble thrombos­
pondins (in turn binding to membrane receptors) have been 
suggested to be capable of binding PtdSer (Savill et al., 1991, 
1992;  Balasubramanian  and  Schroit,  1998;  Imachi  et  al., 
2000; Mevorach, 2000).
Why we need so many receptors and bridging molecules 
is an open question. The general consensus proposed in the 
field has been that not all receptors are expressed on all phago­
cytes, and therefore multiple modes of recognition are needed 
(Savill and Fadok, 2000; Henson et al., 2001a). Although this 
may be true for some phagocytes, many of these PtdSer rec­
ognition mechanisms were first established using macrophages. 
In fact, a typical peritoneal or bone marrow–derived macro­
phage (or macrophage cell lines such as J774) may express up 
to  seven  different  known  PtdSer  recognition  mechanisms.   
If we assume that these various PtdSer recognition modes are 
operational  simultaneously,  questions  arise  about  the  sheer 
number of PtdSer molecules that need to be exposed on a 
given apoptotic cell for binding by these various receptors, 
and the topology of the exposed PtdSer and membrane cur­
vature needed for simultaneous recognition. From the phago­
cyte end, how can all of these receptors engage PtdSer on the 
same apoptotic cell? Because some of the PtdSer recognition 
receptors (such as TIM­4) appear abundant on the macro­
phage surface, one would expect these receptors to compete 
with each other for the same ligand. As soluble bridging mol­
ecules such as Gas6 and Protein S can also be quite abundant 
in serum/plasma (Anderson et al., 2003; Balogh et al., 2005), 
it is puzzling that any free PtdSer would even be accessible for 
binding by direct PtdSer­recognition receptors. The nature of 
the display of PtdSer on the surface of the apoptotic cell, how 
the PtdSer recognition receptors might engage PtdSer, and 
whether co­ligands on apoptotic cells work together with 
PtdSer to influence the specific recognition by phagocytes are 
discussed further in the following paragraphs.
Unanswered questions about the fundamental biology  
of PtdSer exposure
In considering the display of PtdSer, one needs to consider 
both the number of PtdSer molecules that are exposed on the 
surface of an apoptotic cell, as well as how these molecules 
are displayed for recognition by receptors on phagocytes. Are 
glycosylation patterns on the cell surface, alteration of ICAM­1 
epitopes on the cell surface, and exposure of calreticulin. 
Among these, the exposure of PtdSer on the outer leaflet of 
the plasma membrane is the most universally seen alteration 
on the surface of apoptotic cells (Fadok et al., 1992, 2000).   
In fact, PtdSer exposure is the best studied and the most ac­
cepted definition for calling a cell apoptotic (Fadok et al., 
1998). However, several conundrums about PtdSer exposure 
and recognition are worthy of further consideration.
Over the past few years, there has been a paradigm shift 
in the thinking about how PtdSer on apoptotic cells gets rec­
ognized by phagocytes. Previously, it was thought that there 
would be a single PtdSer recognition receptor that would be 
universally used by phagocytes (Henson et al., 2001b). How­
ever, it now appears that multiple distinct receptors on 
phagocytes  can  engage  PtdSer  exposed  on  apoptotic  cells 
(Bratton and Henson, 2008). These PtdSer recognition re­
ceptors come in two primary flavors – those that can bind di­
rectly to PtdSer, and those that indirectly bind PtdSer via 
soluble bridging molecules. Direct­binding PtdSer receptors 
include members of the TIM family (the prototype TIM­4, 
and also TIM­1 and TIM­3; Kobayashi et al., 2007; Miyanishi 
et al., 2007; Santiago et al., 2007; Ichimura et al., 2008; 
DeKruyff et al., 2010; Rodriguez­Manzanet et al., 2010; 
Wong et al., 2010), the seven transmembrane brain angio­
genesis inhibitor 1 (BAI1; Park et al., 2007a), and the atypical 
EGF­motif containing membrane protein Stabilin­2 (Park   
et al., 2007b). In vitro studies coupled with in vivo studies in 
mouse models established a definitive role for the bridging 
molecule MFG­E8, which can bind PtdSer on apoptotic cells 
Figure 2.  Potential effect of find-me signals on phagocytes. Find-
me signals may prime phagocytes to up-regulate the engulfment machin-
ery or cause an increase in expression of engulfment receptors (red) or 
other components that contribute to engulfment (such as cytoplasmic 
signaling proteins or soluble bridging molecules; not depicted).JEM VOL. 207, August 30, 2010  1811
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the ability of other receptors to engage PtdSer on the apop­
totic cell.
Another point to consider is that at least a fraction of the 
exposed PtdSer is oxidized or modified in some other way 
(Tyurin et al., 2008). Some PtdSer recognition mechanisms 
(such as CD36 and MFG­E8) may prefer oxidized PtdSer 
(Borisenko et al., 2004; Fadeel et al., 2007; Tyurin et al., 
2008). If so, and if the modified and native PtdSer molecules 
are simultaneously displayed, this may dictate affinity/avidity 
differences among these receptors for an apoptotic cell. De­
spite the fundamental importance of this scientific problem, 
relatively few groups are pursuing questions on the display of 
PtdSer on apoptotic cells. Moreover, the mechanism by which 
an apoptotic cell is induced to expose its PtdSer (loosely called 
PtdSer flipping) is also not well understood (Ravichandran and 
Lorenz, 2007). The few recent studies of genes regulating PtdSer 
flipping to the outer leaflet in model organisms have been in­
consistent (Wang et al., 2007; Züllig et al., 2007; Venegas and 
Zhou, 2007; Darland­Ransom et al., 2008). New and directed 
efforts toward defining the biochemical and mechanistic as­
pects of PtdSer exposure on apoptotic cells, and the physical 
nature of the PtdSer displayed on the surface (perhaps through 
the recent advances in structural, electron micrographic, and 
imaging tools) are critically needed.
Quantiative and qualitative differences  
among PtdSer receptors
Another question is whether one PtdSer receptor is equal to 
any other PtdSer receptor. Not all of these receptors are ex­
pressed at the same density on the macrophage surface. For   
example, TIM­4 appears to be much more abundant than 
BAI1 on macrophages, whereas Sertoli cells of the testes express 
more BAI1 than TIM­4; however, a key counter argument to 
this density issue is that blocking of individual receptors via an­
tibodies or small interfering RNA seems to suggest that most 
of these receptors play at least some role.
In addition, not all PtdSer recognition receptors may bind 
PtdSer with the same affinity or avidity. If this were the case, 
if one receptor with a higher affinity made the initial contact 
with PtdSer, a second receptor with an inherently lower af­
finity may be better able to engage PtdSer in this context. 
Such a cooperative or sequential binding would also avoid 
the  problem  of  each  of  these  receptors  competing  for   
the same ligand, should they all bind with the same affinity. 
Unfortunately, our knowledge of hierarchy among these   
receptors is minimal. In fact, no systematic studies directly 
comparing the affinities of different receptors exist. The ob­
servation that there may be a threshold level of PtdSer that 
needs to be exposed before phagocytosis of a target is initi­
ated (Borisenko et al., 2003) also points to possible hierarchi­
cal binding should there be differences in affinity between the 
PtdSer recognition receptors. The affinity of these receptors 
for native versus modified PtdSer molecules also needs to be 
considered; if certain receptors were to prefer a modified 
moiety (Borisenko et al., 2004; Fadeel et al., 2007; Tyurin   
et al., 2008), this would allow sequential and cooperative 
there even enough PtdSer molecules on the surface to ac­
commodate  the  various  receptors?  One  study  used  Jurkat   
T cells to attempt to quantitate the number of endogenous Ptd­
Ser molecules that may be exposed during apoptosis (Borisenko 
et al., 2003). They estimated that the exposure of PtdSer on 
live cells is minimal (<0.9 picomoles/million cells); in con­
trast, upon induction of apoptosis by anti­Fas or camptothe­
cin, the PtdSer on the outer leaflet of the membrane goes up 
to >240 picomoles/million cells. Another type of calculation 
based on the surface area of lymphocytes suggests that there 
may be 5­10 million PtdSer molecules exposed on an 
apoptotic thymocyte (unpublished data). Although the precise 
numbers of individual PtdSer recognition receptors expressed 
on a single phagocyte are not available, typical membrane re­
ceptor numbers are in the range of 105 surface molecules/cell 
(Zagursky et al., 1995); if engulfment receptors are expressed 
at typical membrane receptor levels, it is likely that the num­
ber of PtdSer molecules exposed on an apoptotic cell might 
be  enough  to  engage  multiple  PtdSer  receptors.  Because 
there is a >280­fold difference between apoptotic and live 
cells with respect to PtdSer exposure, and this number is 
achieved very early in the apoptotic process (within 1–2 h   
after apoptosis induction; Borisenko et al., 2003), it was sug­
gested that this huge difference in PtdSer exposure between 
live and apoptotic cells may provide the specificity for phago­
cyte recognition of an apoptotic cell. Moreover, a threshold 
increase of PtdSer molecules (eightfold over basal state) needs 
to be exposed on a dying cell before it is subject to macro­
phage­mediated phagocytosis (Borisenko et al., 2003); this 
presumably allows neighboring live cells that may randomly 
expose small amount of PtdSer (for biological reasons inde­
pendent of apoptosis) to be spared.
Although the absolute number of PtdSer molecules ex­
posed may be sufficient to engage available receptors, two 
other issues must be considered. First, the aforementioned cal­
culations assume that PtdSer is free floating on the membrane 
of the apoptotic cell and that every PtdSer molecule is accessi­
ble for recognition by a receptor. However, we know rela­
tively little about how PtdSer is actually displayed on the 
surface of an apoptotic cell. Some studies suggested clustering 
of PtdSer molecules on the surface of a dying cell (Gardai   
et al., 2005), but the size of the clusters and the number of mol­
ecules per cluster, and how universal this is among different 
cell types undergoing apoptosis, are not known. Clustering of 
PtdSer molecules would become particularly relevant if mul­
tiple receptors bind to the PtdSer molecules within a single 
cluster. How can the various receptors topologically arrange 
themselves on the surface of the phagocyte to engage PtdSer 
displayed as a cluster on the apoptotic cell surface? Moreover, 
studies of annexin V binding to PtdSer estimated that each 
molecule of annexin V may cover up or cast a shadow over 
50 phospholipid molecules on the surface (Cézanne et al., 
1999). If the PtdSer were to exist in clusters, then the effective 
density of exposed PtdSer on the apoptotic cell membrane 
may drop quickly. In other words, within a PtdSer cluster, the 
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characterization has lagged, perhaps because of the dominant 
role played by PtdSer in phagocytic recognition.
Could there be an additional ligand (denoted here as X), 
which works as a co­stimulatory ligand, such that phagocytes 
recognize cells displaying “PtdSer+X” as apoptotic cells (Fig. 3)? 
If one considers the analogy of a TCR interacting with a 
peptide+MHC complex (pMHC), it is well established that 
co­stimulatory molecules on the T cell surface (e.g., CD28) 
and their ligands on the APC surface (e.g., B7 family of mole­
cules) critically regulate activation of naive T cells. In the ab­
sence of the co­stimulatory signals, even when the T cell and 
APC interact, the response of the T cell is stunted or aborted. 
Similarly, it is possible that X, coexpressed with PtdSer on the 
surface of apoptotic cells, may engage a counter receptor (the 
CD28 equivalent on the phagocyte), leading to a second sig­
nal. Such PtdSer+X recognition could be useful at several 
levels. First, it may provide additional specificity for PtdSer­
dependent recognition and help phagocytes to avoid ingesting 
cells  displaying  PtdSer  that  was  exposed  independently  of 
apoptosis. Second, engagement of PtdSer+X may help over­
come don’t­eat­me signals simultaneously present on apop­
totic  cells.  Third,  X  could  help  lower  the  threshold  for 
PtdSer­dependent activation of phagocytes; e.g., an eightfold 
change in PtdSer levels is sufficient to promote macrophage 
phagocytosis of a target cell (Borisenko et al., 2003). Fourth, 
X, when engaged by its counter receptor on the phagocyte, 
may help modify the membrane curvature to allow proper 
apposition between the surfaces of the phagocytes and apop­
totic cells. To date, there has only been one such second signal 
identified. Calreticulin was suggested by Gardai et al. (2005) 
as a possible second ligand that works together with PtdSer; 
although this study suggested a role for calreticulin in the sys­
tem used, the calreticulin literature is rather varied depending 
on the nature of cell death and its immunogenicity (Gregory 
and Brown, 2005; Green et al., 2009; Zitvogel et al., 2010). 
Whether additional accessory molecules exist on the surface of 
early apoptotic cells (not secondarily necrotic), whether these 
are exposed basally or concurrent with PtdSer exposure, and 
what their receptors might be on the phagocyte remain to be 
determined. Recently, a phage display approach was used to 
identify  additional  PtdSer­binding  proteins,  although  their 
relevance remains to be determined (Caberoy et al., 2009). 
Perhaps modification of such a method targeted toward iden­
tifying the second ligand could provide an enormous break­
through in the field.
Don’t forget don’t-eat-me signals
Although I primarily considered other molecules that may 
beneficially modify PtdSer recognition, we should not over­
look “don’t­eat­me” signals, even when PtdSer is exposed. 
Presently, there is simply not enough data to know what the 
fold change in PtdSer exposure is on activated B or T lym­
phocytes or myoblasts that transiently expose PtdSer, and 
whether don’t­eat­me signals actively antagonize engulfment 
of these cells. With respect to don’t­eat­me signals, the best 
described to date are CD47 (Gardai et al., 2005, 2006) and 
binding between the same PtdSer recognition receptors on 
the same phagocyte.
What about the differences in signaling pathways induced 
by the various PtdSer recognition receptors? The model of 
“tethering and tickling” proposed by Peter Henson several 
years ago (Henson and Hume, 2006) suggests that in the con­
text of multiple different engulfment receptors engaging varied 
ligands, some may only serve an adhesion function, whereas 
the  others  may  mediate  signaling.  This  could  also  be  true 
among different receptors that engage PtdSer. For example, 
the cytoplasmic and transmembrane regions of TIM­4 appear 
dispensable for promoting engulfment of apoptotic cells (Park 
et al., 2009), suggesting that other membrane proteins may 
conduct signaling subsequent to PtdSer engagement on apop­
totic cells. Similarly, CD36 has a 4­aa cytoplasmic tail and 
likely uses other membrane proteins (such as the vitronectin 
receptor) for signaling (Savill et al., 1992; Albert et al., 1998). 
Moreover, MER is a tyrosine kinase (Lemke and Rothlin, 
2008), whereas BAI1 is a seven­transmembrane protein that 
signals via the ELMO–Dock180–Rac complex (Park et al., 
2009). Therefore, the possibility exists that distinct types of 
signals emanate, allowing a phagocyte to distinguish a live ver­
sus apoptotic cell.
Is PtdSer sufficient?
Based on the original work by Fadok et al. (1992), and subse­
quently confirmed by many groups, blocking PtdSer recogni­
tion via annexin V or other soluble agents that mask PtdSer 
potently inhibits engulfment of apoptotic cells (Fadok et al., 
1998). In fact, no other ligand has been so consistently seen as 
relevant for engulfment in so many different contexts. This 
leads to the question of whether PtdSer is sufficient as an eat­
me signal? One supportive argument is that PtdSer­containing 
liposomes were sufficient to induce responses mimicking those 
initiated by apoptotic cell recognition, such as antiinflamma­
tory responses and cholesterol efflux from phagocytes (Fadok 
et al., 1998; Kiss et al., 2006). However, several counter argu­
ments, albeit some anecdotal, also need to be considered. First, 
many cell types, such as macrophages and activated lympho­
cytes, routinely expose PtdSer at levels sufficient for detection, 
yet are spared from engulfment (Dillon et al., 2000; Hamon   
et al., 2000). Second, necrotic cells expose even greater levels 
of PtdSer (Borisenko et al., 2003), yet they elicit a different re­
sponse from phagocytes than apoptotic cells (apoptotic cells are 
antiinflammatory, whereas necrotic cells are proinflammatory; 
Gallucci et al., 1999). Third, certain epithelial cells and non­
professional  phagocytes  appear  to  engulf  their  apoptotic 
brethren much more efficiently than they engulf apoptotic 
thymocytes, although both target populations were compara­
bly annexin V–positive (unpublished data). Previous studies 
have also suggested that in some cases, even when PtdSer is ar­
tificially incorporated into the outer leaflet of live cells, phago­
cytes do not engulf them (Borisenko et al., 2003). All of these 
observations suggest that ligands or binding parameters other 
than the exposure of PtdSer must be considered. The idea 
of additional ligands on apoptotic cells is not new, but their JEM VOL. 207, August 30, 2010  1813
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address some key unanswered questions in the field may bene­
fit from approaches that have proved highly useful in other 
systems dealing with recognition between two distinct cell 
types, such as T lymphocytes and APCs (Gascoigne et al., 
2009; Fooksman et al., 2010; Reichardt et al., 2010; Fig. 3). 
The specific recognition of an apoptotic cell by a phagocyte 
is similar in several respects to T cell recognition of a pMHC 
complex on an APC. First, a T cell would have to recognize 
a specific antigen bearing APC among other APCs, analo­
gous to a phagocyte trying to specifically recognize a dying 
cell among all the live cells within tissue or circulation. Sec­
ond, like the T cell–APC interface, multiple receptor–ligand 
pairs are part of the phagocyte–apoptotic cell interface, al­
though their roles are not well defined. Third, like T cells 
which can “sniff” many APCs without engaging in a strong 
interaction (Cahalan and Parker, 2005, 2008), macrophages 
engage live cells frequently, but quickly let them go because 
of the presence of don’t­eat­me signals (Brown et al., 2002). 
Fourth, similar to a T cell–APC interaction where intracellu­
lar signals initiate T cell responses, the signals mediated dur­
ing the phagocyte–apoptotic cell interaction also lead to the 
engulfment of the dying cell and secretion of antiinflamma­
tory mediators, which are part of the immunologically silent 
clearance (Henson, 2005).
However, there are also several key differences, the most 
important being that the particular TCR–pMHC interaction 
critically anchors the T cell­APC conjugation. In the context 
of apoptotic cells, although PtdSer may be loosely considered 
as an equivalent of the pMHC, there is not an equivalent of 
CD31 (Brown et al., 2002). Because of the relevance of 
CD47 in red blood cells, the CD47 literature is clearly more 
advanced. Gardai et al. (2005) showed that CD47 could act 
as a potent don’t­eat­me signal and inhibit engulfment of 
cells displaying PtdSer. They even suggested that in the ab­
sence of CD47, the nature of the PtdSer display might change. 
However, the extent of use of CD47 as a don’t­eat­me signal 
by different cell types is unclear. At this point, only a handful 
of studies have systematically addressed don’t­eat­me signals, 
and don’t­eat­me mechanisms of action are not well under­
stood. This may in part stem from technical issues. First, it is 
very difficult to use lack of engulfment as an assay, as in 
most typical phagocytosis assays the engulfment ranges from   
5–50%. Second, given the current view that multiple ligands 
and receptors may be operational, it is difficult to systemati­
cally analyze such lack of engulfment in the eukaryotic con­
text  and  define  the  role  of  individual  biologically  and 
functionally relevant molecules. However, model organisms, 
such as C. elegans, in which the death and uptake of single 
cells can be tracked in real time (Hoeppner et al., 2001), may 
prove useful for genetic studies of don’t­eat­me signals, and 
in turn extend to mammalian systems.
Concluding thoughts and future directions
The engulfment field is relatively young; nevertheless, the 
appreciation that apoptotic cell clearance is a process relevant 
for many states of health and disease attracted many investiga­
tors  from  diverse  fields,  resulting  in  a  significant  increase   
in our knowledge during the past few years. But efforts to 
Figure 3.  A possible engulfment synapse during apoptotic cell clearance. In a speculative model, an engulfment synapse may help phagocyte 
binding to and subsequent internalization of apoptotic target cells. There appears to be some clear similarities between T cell–APC recognition and 
phagocyte–apoptotic cell interactions (see text for more details). However, whereas the T cell–APC interaction is anchored by MHC+peptide interaction 
with the TCR, the PtdSer exposed on apoptotic cells perhaps may be more homogeneous (except for modifications such as oxidation, etc.), and is likely 
recognized by multiple PtdSer recognition receptors on the phagocyte. How the PtdSer is displayed on the apoptotic cells and how the different engulf-
ment receptors are arranged on the phagocyte are not yet defined. One could speculate that a second signal analogous to B7 (ligand X) on the apoptotic 
cell may engage a co-stimulatory receptor analogous to CD28 (receptor X) on the phagocyte, thereby providing specificity, overcoming don’t-eat-me 
signals, lowering the threshold for phagocyte priming, and/or altering membrane curvature.1814 Find-me and eat-me signals of apoptotic cells | Ravichandran
immunogenic versus nonimmunogenic cell death (Green and 
Kroemer, 2005; Green et al., 2009) and how this can be ma­
nipulated in a therapeutically beneficial way. Detailed under­
standing of how a phagocyte encounters and engulfs an apoptotic 
cell could be used to increase engulfment in situations deemed 
to be deficiencies of engulfment. Moreover, defining the sub­
tleties of multiple receptors engaging the same or similar   
ligands may help us understand how the post­engulfment re­
sponses of phagocytes (such as antiinflammatory mediator sig­
naling) may be modified. This type of information could be 
important for designing drugs that could trigger engulfment 
receptors to mimic physiological engulfment; the antiinflam­
matory mediators elicited by these drugs could be useful for 
resolving inflammation in many different conditions and treat­
ing autoimmunity.
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